A new study suggests that amlodipine, a widely used blood pressure medication, could help manage ADHD symptoms.

Clinical Relevance in Human Populations: Polygenic risk score analysis using the UK Biobank demonstrated that individuals with a high ADHD genetic burden who were prescribed amlodipine exhibited ...

High blood pressure is a major health concern, affecting about 10% of adults worldwide. Many people with this condition rely ...

Z Pharmaceuticals, a CNS-focused therapeutic development specialist, today announced the publication of a groundbreaking study in The Journal of Pharmacology and Experimental Therapeutics, unveiling ...

A new study suggests that people taking a common type of blood pressure medication, known as Calcium Channel Blockers (CCBs), ...

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder ...

drowsiness or dizziness Angiotensin II receptor blockers These may be used to treat heart failure or after a heart attack. dizziness, headache, fatigue, and others Calcium channel blockers These ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Heart disease is the leading cause of death for all racial and ethnic groups in the United States. This lifestyle change could change that.

an L-type calcium channel blocker (LTCC), as a foundation for a novel therapy for ADHD. The findings provide robust validation of 3Z's cutting-edge high-throughput drug discovery platform and ...